Abstract
Genetic diseases are a significant global health concern, with millions of individuals affected by inherited disorders. Advances in biotechnology have revolutionized the field of genetic disease screening, enabling early detection, accurate diagnosis, and personalized treatment options. Technologies such as next-generation sequencing (NGS), CRISPR-based tools, and gene editing have opened new avenues for screening genetic disorders, allowing for precise identification of mutations and variants. This article discusses recent biotechnological advances in genetic disease screening, focusing on their impact on healthcare, challenges in implementation, and future directions.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Austra Lian, Screening Michael Taylor, Emma Richards (Author)